Erratum: Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors
更正:在患有 TRK 融合肉瘤及相关间叶肿瘤的儿科患者中选择性停用拉罗替尼
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-00353
Mascarenhas, Leo; DuBois, Steven G; Albert, Catherine M; Bielack, Stefan; Orbach, Daniel; Federman, Noah; Geoerger, Birgit; Nagasubramanian, Ramamoorthy; Zhang, Yizhou; Chisholm, Julia; Melcon, Soledad Gallego; Goto, Hiroaki; Morgenstern, Daniel A; Owens, Cormac; Pappo, Alberto S; Perreault, Sébastien; Schulte, Johannes H; Shukla, Neerav; Zwaan, Christian Michel; Neu, Natascha; Bernard-Gauthier, Vadim; De La Cuesta, Esther; van Tilburg, Cornelis M; Laetsch, Theodore W